admin – Page 3229 – Get News Story

IgA Nephropathy Clinical Trials Market 2034: EMA, PDMA, FDA Approval, Medication, Treatment Market, Revenue, Statistics, Therapies, and Companies by DelveInsight

“IgA Nephropathy Therapeutics Market”

IgA Nephropathy companies include Novartis, RemeGen, Calliditas Therapeutics AB, Travere Therapeutics, Inc., Omeros Corporation, Chinook Therapeutics, Inc., Vera Therapeutics, Inc., Otsuka Pharmaceutical, and others

(Albany, USA) DelveInsight’s “IgA Nephropathy Market Insights, Epidemiology, and Market Forecast-2034” report delivers an in-depth understanding of IgA Nephropathy, historical and forecasted epidemiology as well as the IgA Nephropathy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.

The IgA Nephropathy market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted IgA Nephropathy market size from 2020 to 2034, segmented by seven major markets. The Report also covers current IgA Nephropathy treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best opportunities and assesses the underlying potential of the IgA Nephropathy market.

Request for a Free Sample Report @ IgA Nephropathy Market Forecast

Some facts of IgA Nephropathy Market Report are:

The total IgA Nephropathy market size in the 7MM and China is approximately USD 500 million in 2022 and is projected to increase during the forecast period (2023–2034).
In 2022, the IgA Nephropathy Market Size was the highest in the US among the 7MM, accounting for approximately USD 160 million, which is further estimated to increase by 2034.
Some of the key companies in the IgA Nephropathy therapeutics market include Calliditas Therapeutics AB, Travere Therapeutics, Inc., Omeros Corporation, Novartis, RemeGen, Chinook Therapeutics, Inc., Vera Therapeutics, Inc., Otsuka Pharmaceutical, and others
IgA Nephropathy is more common in men than women.
The prevalence is modest in the United States (10–20% of primary glomerulonephritis), higher in some European countries (20–30%) and highest in developed countries in Asia (40–50%).
A systematic review of biopsy-based studies spanning multiple countries suggests an overall population incidence of at least 2.5 per 100,000. Only one study in this review was from Japan, and most were from Europe and North America.
According to the surveyed literature, this disorder is thought to follow a benign course in most cases. However, many patients are at risk for slow progression to ESRD, which develops in approximately 15% of patients by 10 years and 20% by 20 years, though these percentages depend on how the disease is defined.
On May 25, 2024, Novartis atrasentan Phase III data show clinically meaningful proteinuria reduction further advancing company’s IgA nephropathy (IgAN) portfolio. Atrasentan is an investigational potent and selective oral ETA receptor antagonist, currently in Phase III development for IgAN and early-stage development for other rare kidney diseases. The ALIGN study (NCT04573478) is a global, randomized, multicenter, double-blind, placebo-controlled Phase III clinical trial comparing the efficacy and safety of atrasentan versus placebo in patients with IgAN at risk of progressive loss of kidney function.
On May 24, 2024, HI-Bio Presents Positive Interim Results from Phase 2 IGNAZ Study of Felzartamab in IgA Nephropathy at 61st European Renal Association (ERA) Congress. Felzartamab is an investigational therapeutic human monoclonal antibody directed against CD38, a protein expressed on mature plasma cells. Felzartamab has been shown in clinical studies to selectively deplete CD38+ plasma cells, which may allow applications that ultimately improve clinical outcomes in a broad range of diseases driven by pathogenic antibodies.
On May 28, 2024, Vera Therapeutics, Inc. (Nasdaq: VERA) announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to atacicept for the treatment of IgAN. The designation is based on an assessment of data from the Phase 2b ORIGIN clinical trial of atacicept for IgAN. Atacicept is an investigational recombinant fusion protein; Vera believes atacicept is positioned for best-in-class potential, targeting B cells and plasma cells to reduce autoantibodies.

IgA Nephropathy Overview

IgA nephropathy, also known as Berger’s disease, is a kidney disorder characterized by the buildup of immunoglobulin A (IgA) antibodies in the kidneys. This abnormal immune response leads to inflammation and damage to the glomeruli, the filtering units of the kidneys. The exact cause of IgA nephropathy is unclear, but it is believed to involve a combination of genetic predisposition and environmental triggers, such as infections or autoimmune conditions. Patients may initially present with symptoms like blood in the urine (hematuria) or proteinuria, although some individuals may remain asymptomatic for years. Over time, IgA nephropathy can progress to chronic kidney disease and ultimately kidney failure. Treatment aims to manage symptoms, reduce inflammation, and slow disease progression through medications, blood pressure control, dietary changes, and lifestyle modifications. Close monitoring and regular follow-up with a healthcare provider are essential for managing IgA nephropathy effectively.

Learn more about IgA Nephropathy treatment algorithms in different geographies, and patient journeys. Contact to receive a sample @ IgA Nephropathy Prevalence

IgA Nephropathy Market

The IgA Nephropathy market outlook of the report helps to build a detailed comprehension of the historical, current, and forecasted IgA Nephropathy market trends by analyzing the impact of current IgA Nephropathy therapies on the market and unmet needs, and drivers, barriers, and demand for better technology.

This segment gives a thorough detail of the IgA Nephropathy market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated IgA Nephropathy market data are presented with relevant tables and graphs to give a clear view of the market at first sight.

According to DelveInsight, the IgA Nephropathy market in 7MM is expected to witness a major change in the study period 2020-2034.

IgA Nephropathy Epidemiology

The IgA Nephropathy epidemiology section provides insights into the historical and current IgA Nephropathy patient pool and forecasted trends for seven individual major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the IgA Nephropathy market report also provides the diagnosed patient pool, trends, and assumptions.

Explore more about IgA Nephropathy Epidemiology @ IgA Nephropathy Market Dynamics

IgA Nephropathy Drugs Uptake

This section focuses on the uptake rate of the potential IgA Nephropathy drugs recently launched in the IgA Nephropathy market or expected to be launched in 2020-2034. The analysis covers the IgA Nephropathy market uptake by drugs, patient uptake by therapies, and sales of each drug.

IgA Nephropathy Drugs Uptake helps in understanding the drugs with the most rapid uptake and the reasons behind the maximal use of new drugs and allows the comparison of the drugs based on IgA Nephropathy market share and size, which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

IgA Nephropathy Pipeline Development Activities

The IgA Nephropathy report provides insights into different therapeutic candidates in Phase II, and Phase III stages. It also analyses IgA Nephropathy key players involved in developing targeted therapeutics.

Request for a sample report to understand more about the IgA Nephropathy pipeline development activities @ IgA Nephropathy Therapies and Drugs

IgA Nephropathy Therapeutics Assessment

Major key companies are working proactively in the IgA Nephropathy Therapeutics market to develop novel therapies which will drive the IgA Nephropathy treatment markets in the upcoming years are Calliditas Therapeutics AB (NASDAQ: CALT), Travere Therapeutics, Inc. (NASDAQ: TVTX), Omeros Corporation (NASDAQ: OMER), Novartis Pharmaceuticals (SWX: NOVN), Chinook Therapeutics, Inc. (NASDAQ: KDNY), Vera Therapeutics, Inc. (NASDAQ: VERA), and Otsuka Pharmaceutical (TYO: 4578), among others.

Learn more about the emerging IgA Nephropathy therapies & key companies @ IgA Nephropathy Clinical Trials and FDA Approvals

IgA Nephropathy Report Key Insights

1. IgA Nephropathy Patient Population

2. IgA Nephropathy Market Size and Trends

3. Key Cross Competition in the IgA Nephropathy Market

4. IgA Nephropathy Market Dynamics (Key Drivers and Barriers)

5. IgA Nephropathy Market Opportunities

6. IgA Nephropathy Therapeutic Approaches

7. IgA Nephropathy Pipeline Analysis

8. IgA Nephropathy Current Treatment Practices/Algorithm

9. Impact of Emerging Therapies on the IgA Nephropathy Market

Table of Contents

1. Key Insights

2. Executive Summary

3. IgA Nephropathy Competitive Intelligence Analysis

4. IgA Nephropathy Market Overview at a Glance

5. IgA Nephropathy Disease Background and Overview

6. IgA Nephropathy Patient Journey

7. IgA Nephropathy Epidemiology and Patient Population

8. IgA Nephropathy Treatment Algorithm, Current Treatment, and Medical Practices

9. IgA Nephropathy Unmet Needs

10. Key Endpoints of IgA Nephropathy Treatment

11. IgA Nephropathy Marketed Products

12. IgA Nephropathy Emerging Therapies

13. IgA Nephropathy Seven Major Market Analysis

14. Attribute Analysis

15. IgA Nephropathy Market Outlook (7 major markets)

16. IgA Nephropathy Access and Reimbursement Overview

17. KOL Views on the IgA Nephropathy Market

18. IgA Nephropathy Market Drivers

19. IgA Nephropathy Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

About DelveInsight

DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/ats-conference-coverage

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: IgA Nephropathy Clinical Trials Market 2034: EMA, PDMA, FDA Approval, Medication, Treatment Market, Revenue, Statistics, Therapies, and Companies by DelveInsight

MASH Market Report 2034: Statistics, Revenue, Patient Pool, EMA, PDMA, FDA Approvals, Clinical Trials, Medication, MOA, ROA and Companies by DelveInsight

“MASH Market”

MASH Companies are Boehringer Ingelheim, Hepagene, Eli Lilly and Company, Hepion Pharmaceuticals, Ionis Pharmaceuticals, Galectin Therapeutics, Novo Nordisk A/S, Merck & Co., Zealand Pharma, Hanmi Pharmaceutical, Inventiva Pharma, Cirius Therapeutics, HighTide Biopharma, Pfizer, Lipocine, Corcept Therapeutics, Poxel SA, Enyo Pharmaceuticals, Akero Therapeutics, Zydus Therapeutics, 89bio, Viking Therapeutics, Boston Pharmaceuticals, Gilead Sciences, CytoDyn, Sagimet Biosciences, and others.

(Albany, USA) DelveInsight’s Metabolic Dysfunction-Associated Steatohepatitis Market Insights report includes a comprehensive understanding of current treatment practices, MASH emerging drugs, market share of individual therapies, and current and forecasted market size from 2020 to 2034, segmented into 7MM [the United States, the EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan].

The MASH market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted MASH market size from 2020 to 2034, segmented by seven major markets. The Report also covers current MASH treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best opportunities and assesses the underlying potential of the MASH market.

Key Takeaways from the Metabolic Dysfunction-Associated Steatohepatitis Market Report

The total MASH market size in the 7MM was approximately USD 2,114 million in 2023 and is projected to increase during the forecast period (2024–2034).

In 2023, there were an estimated 42 million prevalent cases of MASH in the 7MM. Out of these, a total of ~15 million cases were diagnosed, and this number is projected to increase by the end of 2034 in the 7MM.
Leading MASH companies such as Inventiva Pharma, Novo Nordisk A/S, Cirius Therapeutics, Akero Therapeutics, 89bio, Boehringer Ingelheim, Zealand Pharma, Galectin Therapeutics, Lipocine, Viking Therapeutics, Eli Lilly and Company, Boston Pharmaceuticals, Pfizer, HighTide Biopharma, CytoDyn, Merck & Co., Hanmi Pharmaceutical, Hepagene (Shanghai), Hepion Pharmaceuticals, Enyo Pharmaceuticals, Gilead Sciences, Poxel SA, Zydus Therapeutics, Sagimet Biosciences, Ionis Pharmaceuticals, Corcept Therapeutics, and others are developing novel MASH drugs that can be available in the MASH market in the coming years.
The promising MASH therapies in the pipeline include Lanifibranor (IVA337), Semaglutide, Azemiglitazone (MSDC-0602K), Efruxifermin (EFX), BIO89-100 (Pegozafermin), Survodutide (BI 456906), GR-MD-02 (Belapectin), LPCN1144, VK2809, Tirzepatide, BOS-580, Ervogastat (PF-06865571) + Clesacostat (PF-05221304), HTD1801, Leronlimab (PRO 140), Efinopegdutide, HPG1860, Rencofilstat (CRV431), EYP001 (Vonafexor), Semaglutide/Cilofexor/Firsocostat, PXL065, Saroglitazar Magnesium, Denifanstat (TVB-2640), ION224, Miricorilant (CORT118335), and others.
In March 2024, Madrigal Pharmaceuticals’ groundbreaking product, REZDIFFRA (resmetirom), a once-daily, oral THR-ß agonist, received accelerated endorsement from the US FDA based on results from the Phase III MAESTRO-NASH trial. This approval marks a significant stride in the medical landscape, as REZDIFFRA becomes the inaugural and sole FDA-sanctioned therapy for adults afflicted with non-cirrhotic MASH, accompanied by moderate to advanced liver scarring (fibrosis) corresponding to stages F2–F3 fibrosis.

Discover which therapies are expected to grab the major MASH market share @ Metabolic Dysfunction-Associated Steatohepatitis Market Report

Metabolic Dysfunction-Associated Steatohepatitis Overview

Metabolic dysfunction-associated steatohepatitis (MASH) is a progressive liver disease that stems from metabolic dysfunction, often linked to obesity, diabetes, and other conditions of metabolic syndrome. MASH is characterized by the accumulation of fat in liver cells, accompanied by inflammation and liver cell injury, which can progress to fibrosis, cirrhosis, or even liver cancer.

The primary drivers of MASH include insulin resistance, obesity, type 2 diabetes, and dyslipidemia. Genetic predisposition and a sedentary lifestyle also play significant roles. Environmental factors, such as a poor diet high in sugars and fats, exacerbate the condition.

MASH is often asymptomatic in its early stages. When MASH symptoms occur, they can include fatigue, vague abdominal discomfort, or pain in the upper right quadrant. In advanced stages, signs of liver dysfunction such as jaundice, swelling of the abdomen or legs, and confusion may arise.

MASH Diagnosis involves a combination of clinical history, physical examination, and diagnostic tests. Blood tests measuring liver enzymes (ALT, AST) often indicate liver inflammation. Imaging techniques like ultrasound, MRI, or FibroScan can identify liver fat and fibrosis. In some cases, a liver biopsy is required to confirm the diagnosis and assess disease severity.

Metabolic Dysfunction-Associated Steatohepatitis Epidemiology Segmentation

The MASH epidemiology section provides insights into the historical and current MASH patient pool and forecasted trends for the 7MM. It helps recognize the causes of current and forecasted patient trends by exploring numerous studies and views of key opinion leaders.

The MASH market report proffers epidemiological analysis for the study period 2020–2034 in the 7MM segmented into:

Prevalent Cases of MASH
Diagnosed Prevalent Cases of MASH
Gender-specific Diagnosed Prevalent Cases of MASH
Severity-specific Diagnosed Prevalent Cases of MASH

MASH Treatment Market

The approval of REZDIFFRA (resmetirom) in March 2024 represents a pivotal achievement in medical innovation, transforming the treatment landscape for MASH disease. This groundbreaking therapy addresses the root causes of MASH, offering renewed hope to patients grappling with this challenging condition. Clinical trials have shown impressive results, with REZDIFFRA effectively reducing symptoms like inflammation and fibrosis, enhancing liver function, and improving patients’ quality of life. By providing healthcare professionals with a robust treatment option, this approval addresses a critical unmet need and has the potential to significantly alleviate the complications linked to advanced liver disease.

The prevalence of MASLD is strongly linked to type 2 diabetes mellitus and obesity, particularly in individuals with a higher body mass index. However, MASLD occurrence is reduced in T2DM patients receiving treatments such as sodium-glucose cotransporter-2 (SGLT2) inhibitors, GLP-1 receptor agonists, and insulin. Vitamin E, with its antioxidant properties, is regarded as a first-line pharmacological option for managing MASH, especially when dietary and lifestyle interventions are insufficient.

To know more about MASH treatment guidelines, visit @ Metabolic Dysfunction-Associated Steatohepatitis Management

Metabolic Dysfunction-Associated Steatohepatitis Pipeline Therapies and Key Companies

Lanifibranor (IVA337): Inventiva Pharma
Semaglutide: Novo Nordisk A/S
Azemiglitazone (MSDC-0602K): Cirius Therapeutics
Efruxifermin (EFX): Akero Therapeutics
BIO89-100 (Pegozafermin): 89bio
Survodutide (BI 456906): Boehringer Ingelheim/Zealand Pharma
GR-MD-02 (Belapectin): Galectin Therapeutics
LPCN1144: Lipocine
VK2809: Viking Therapeutics
Tirzepatide: Eli Lilly and Company
BOS-580: Boston Pharmaceuticals
Ervogastat (PF-06865571) + Clesacostat (PF-05221304): Pfizer
HTD1801: HighTide Biopharma
Leronlimab (PRO 140): CytoDyn
Efinopegdutide: Merck & Co./Hanmi Pharmaceutical
HPG1860: Hepagene (Shanghai)
Rencofilstat (CRV431): Hepion Pharmaceuticals
EYP001 (Vonafexor): Enyo Pharmaceuticals
Semaglutide/ Cilofexor/ Firsocostat: Gilead Sciences
PXL065: Poxel SA
Saroglitazar Magnesium: Zydus Therapeutics
Denifanstat (TVB-2640): Sagimet Biosciences
ION224: Ionis Pharmaceuticals
Miricorilant (CORT118335): Corcept Therapeutics

Discover more about MASH drugs in development @ Metabolic Dysfunction-Associated Steatohepatitis Clinical Trials and Advancements

MASH Market Dynamics

The MASH market dynamics are expected to change in the coming years. Growing research activities and multiple clinical trials for MASH, driven by the rapid surge in its prevalence due to rising obesity and type 2 diabetes rates, highlight an active drug development pipeline and an expanding market size. The large pool of patients and lucrative growth opportunities present attractive prospects for key players, further supported by ongoing preclinical studies aimed at advancing imaging techniques for MASH diagnosis, potentially eliminating the need for invasive biopsy-based histopathological confirmation.

Furthermore, potential therapies are being investigated for the treatment of MASH, and it is safe to predict that the treatment space will significantly impact the MASH market during the forecast period. Moreover, the anticipated introduction of emerging therapies with improved efficacy and a further improvement in the diagnosis rate are expected to drive the growth of the MASH market in the 7MM.

However, several factors may impede the growth of the MASH market. Lack of awareness and negligence in the early stages of MASH by physicians often lead to disease progression, culminating in irreversible damage where liver transplantation becomes the only viable option. Diagnosing advanced MASH typically requires procedures like liver biopsy, which are costly, invasive, and risky. Regulatory challenges also pose hurdles, as the FDA mandates achieving one MASH endpoint for approval, while the EMA’s draft guidance requires efficacy in both endpoints, potentially delaying first-mover approvals in major European markets. Additionally, access to expensive MASH treatments may be limited in certain regions, further hindering patient adoption.

Moreover, MASH treatment poses a significant economic burden and disrupts patients’ overall well-being and QOL. Furthermore, MASH market growth may be offset by failures and discontinuation of emerging therapies, unaffordable pricing, market access and reimbursement issues, and a shortage of healthcare specialists. In addition, the undiagnosed, unreported cases and the unawareness about the disease may also impact MASH market growth.

Download the report to understand which factors are driving MASH drugs and therapies in pipeline @ Metabolic Dysfunction-Associated Steatohepatitis Treatment Market

Scope of the Metabolic Dysfunction-Associated Steatohepatitis Market Report

Study Period: 2020–2034
Coverage: 7MM [the United States, the EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan].
Metabolic Dysfunction-Associated Steatohepatitis CAGR: 17.9 %
Metabolic Dysfunction-Associated Steatohepatitis Market Size in 2023: USD 2.1 Billion
Key Metabolic Dysfunction-Associated Steatohepatitis Companies: Hepion Pharmaceuticals (NASDAQ: HEPG), Ionis Pharmaceuticals (NASDAQ: IONS), Galectin Therapeutics (NASDAQ: GALT), Novo Nordisk A/S (NYSE: NVO), Cirius Therapeutics (Private), HighTide Biopharma (TSX-V: HBT), Boehringer Ingelheim (Private), Hepagene (Private), Eli Lilly and Company (NYSE: LLY), Pfizer (NYSE: PFE), Lipocine (NASDAQ: LPCN), Corcept Therapeutics (NASDAQ: CORT), Poxel SA (EPA: POXEL), Enyo Pharmaceuticals (Private), Akero Therapeutics (NASDAQ: AKRO), Zydus Therapeutics (NSE: ZYDUSLIFE), 89bio (NASDAQ: ETNB), Viking Therapeutics (NASDAQ: VKTX), Boston Pharmaceuticals (Private), Gilead Sciences (NASDAQ: GILD), Merck & Co. (NYSE: MRK), Zealand Pharma (CPH: ZEAL), Hanmi Pharmaceutical (KRX: 128940), Inventiva Pharma (EPA: IVA), CytoDyn (OTCQB: CYDY), Sagimet Biosciences (NASDAQ: SGMT).
Key Pipeline Metabolic Dysfunction-Associated Steatohepatitis Therapies: Lanifibranor (IVA337), Semaglutide, Azemiglitazone (MSDC-0602K), Efruxifermin (EFX), BIO89-100 (Pegozafermin), Survodutide (BI 456906), GR-MD-02 (Belapectin), LPCN1144, VK2809, Tirzepatide, BOS-580, Ervogastat (PF-06865571) + Clesacostat (PF-05221304), HTD1801, Leronlimab (PRO 140), Efinopegdutide, HPG1860, Rencofilstat (CRV431), EYP001 (Vonafexor), Semaglutide/Cilofexor/Firsocostat, PXL065, Saroglitazar Magnesium, Denifanstat (TVB-2640), ION224, Miricorilant (CORT118335), and others
Therapeutic Assessment: Metabolic Dysfunction-Associated Steatohepatitis current marketed and emerging therapies
Metabolic Dysfunction-Associated Steatohepatitis Market Dynamics: Key Market Forecast Assumptions of Emerging Metabolic Dysfunction-Associated Steatohepatitis Drugs and Market Outlook
Competitive Intelligence Analysis: SWOT analysis and Market entry strategies
Unmet Needs, KOL’s views, Analyst’s views, Metabolic Dysfunction-Associated Steatohepatitis Market Access and Reimbursement

Download the report to understand which factors are driving MASH market trends @ Metabolic Dysfunction-Associated Steatohepatitis Market Trends

Table of Contents

1. Key Insights

2. Report Introduction

3. Country-wise MASH Market Overview at a Glance

4. MASH Market Overview by Therapeutic Class

5. Methodology of MASH Epidemiology and Market

6. Executive Summary

7. Key Events

8. Disease Background and Overview

9. MASH Epidemiology and Patient Population

10. MASH Patient Journey

11. Marketed MASH Drugs

12. Emerging MASH Drugs

13. MASH Market Analysis

14. Key Opinion Leaders’ Views

15. SWOT Analysis

16. Unmet needs

17. Market Access and Reimbursement

18. Appendix

19. Report Methodology

20. DelveInsight Capabilities

21. Disclaimer

About DelveInsight

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: MASH Market Report 2034: Statistics, Revenue, Patient Pool, EMA, PDMA, FDA Approvals, Clinical Trials, Medication, MOA, ROA and Companies by DelveInsight

ZenaTech’s (Nasdaq: ZENA) DaaS Model, Strategic Acquisitions Drive 92% Revenue Growth in Q1

The commercial and military drone sectors are entering a high-growth phase, driven by rapid tech innovation and expanding use across industries. The global commercial drone market hit $30.02 billion in 2024 and is projected to grow at a 10.6% CAGR through 2030, per Grand View Research. Meanwhile, military drone spending is expected to more than double from $24.25 billion in 2025 to $56.69 billion by 2033, growing at 11.2% CAGR, according to Straits Research.

With drones transforming agriculture, logistics, public safety, and defense, investors are scanning the skies for breakout players. ZenaTech (Nasdaq: ZENA) is an AI-driven drone and software company that is making strategic moves that position it as a rising force in this rapidly evolving sector.

Diversified Drone Applications Fuel Growth

ZenaTech has built a multi-vertical drone business through its subsidiary ZenaDrone, with solutions tailored for agriculture, infrastructure inspection, inventory management, public safety, and defense. The company’s AI-powered drones — including the ZenaDrone 1000 and its IQ Nano and IQ Square models — serve both indoor and outdoor use cases, enabling everything from 3D mapping and barcode scanning to power line inspections and real-time surveillance.

A key differentiator is ZenaTech’s embrace of a Drone-as-a-Service (DaaS) model. Much like SaaS platforms or ride-hailing services, the company enables clients to access drones on a subscription or pay-per-use basis — no hardware purchases, pilots, or maintenance required. This recurring-revenue model lowers adoption barriers while providing scalable upside across multiple sectors and geographies.

Poised to Capture Agricultural Sector Growth in Europe

In early May, ZenaTech announced the opening of its European headquarters in Dublin, Ireland, a strategic move that places it near critical logistics infrastructure and opens access to high-growth EU markets.

Europe’s agricultural drone market is projected to grow from $4.6 billion in 2023 to over $43 billion by 2032, a staggering 28.6% CAGR. Farmers across the continent are adopting drone technologies for seeding, spraying, monitoring, and data collection. ZenaTech is targeting this growth with specialized DaaS offerings for precision agriculture, renewable energy, and construction.

According to CEO Shaun Passley, Ph.D., “our AI-powered drone solutions are designed to boost crop yields while reducing operational costs and provide smart, data-driven insights.” With favorable regulatory tailwinds and a continental focus on sustainability, ZenaTech is well-positioned to benefit from rising demand in this space.

Launching Drone-Based Cleaning Services in Dubai

One of the company’s most strategically significant initiatives is its recent expansion into Dubai, where it is launching a drone-based exterior building cleaning service. Leveraging the IQ Square, a large-format drone equipped with tethered water and power lines, ZenaTech aims to tap into a fast-growing niche.

Dubai’s high-rise skyline, frequent sandstorms, and mandated cleaning standards create a natural use case for drone-enabled washing services. The global drone cleaning market is expected to triple from $4.36 billion in 2023 to $13.2 billion by 2030. As a first mover in this region, ZenaTech is looking to establish an early foothold in an emerging sector of urban infrastructure management.

Advancing Defense and Proprietary Innovation

ZenaTech is also developing its presence in defense, with its IQ Nano drone swarms designed for autonomous surveillance, RFID and barcode scanning, and battlefield logistics. These lightweight drones, available in compact 10×10 and 20×20-inch formats, are being tested for military and commercial use and are in the process of obtaining Blue UAS certification, enabling sales to U.S. government agencies.

Vertical integration is another strength. Through its Taiwan-based Spider Vision Sensors subsidiary, ZenaTech has developed proprietary cameras that align with U.S. National Defense Authorization Act (NDAA) compliance requirements. Internal control over hardware development supports faster iteration and greater cost control across its product lines.

Revenue Growth and Aggressive Scaling

ZenaTech reported $1.13 million in Q1 2025 revenue, a 92% year-over-year increase. Much of this momentum stems from the DaaS segment, bolstered by a disciplined acquisition strategy. Recent purchases include Oregon’s Weddle Surveying and Florida’s KJM Land Surveying, both of which enhance its geospatial data and infrastructure services.

In the enterprise software space, ZenaTech also acquired UK-based Othership, a SaaS workplace platform. The company has opened a drone testing facility in Turkey and expanded hiring in the UAE, Taiwan, and the United States to support R&D and manufacturing needs.

While operating expenses rose meaningfully in the quarter, the company has signaled a long-term growth focus. Management also noted it is evaluating over 20 potential acquisitions within the next year, underscoring its ambitions to scale rapidly through both organic and inorganic strategies.

Bottom Line

As the global drone market accelerates, ZenaTech (Nasdaq: ZENA) is carving out a role as a nimble and diversified competitor. Its DaaS model enables recurring revenue and ease of customer adoption, while its international expansion, particularly into Europe and Dubai, offers near-term growth catalysts.

With a strong product pipeline, proprietary innovations, strategic acquisitions, and accelerating revenue, ZenaTech may offer investors an intriguing early-stage opportunity in the broader drone revolution.

Disclaimers: RazorPitch Inc. “RazorPitch” is not operated by a licensed broker, a dealer, or a registered investment adviser. This content is for informational purposes only and is not intended to be investment advice. The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performances are not statements of historical fact and may be forward-looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward-looking statements in this action may be identified through the use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quote; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor’s investment may be lost or impaired due to the speculative nature of the companies profiled. RazorPitch has been retained and compensated by ZenaTech Ltd. to assist in the production and distribution of content related to ZENA. RazorPitch is responsible for the production and distribution of this content. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. This content is for informational purposes only; you should not construe any such information or other material as legal, tax, investment, financial, or other advice. Nothing contained in this article constitutes a solicitation, recommendation, endorsement, or offer by RazorPitch or any third-party service provider to buy or sell any securities or other financial instruments. All content in this article is information of a general nature and does not address the circumstances of any particular individual or entity. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. RazorPitch is not a fiduciary by virtue of any persons use of or access to this content.

Media Contact
Company Name: RazorPitch
Contact Person: Mark McKelvie
Email: Send Email
City: NAPLES
State: Florida
Country: United States
Website: https://razorpitch.com/

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: ZenaTech’s (Nasdaq: ZENA) DaaS Model, Strategic Acquisitions Drive 92% Revenue Growth in Q1

Riana Malia Reveals How to Break Free from Limiting Patterns in New Ideal Practice Podcast Episode

In a powerful new episode of the Ideal Practice podcast, host Wendy Pitts Reeves sits down with Riana Malia, a transformation coach and author known for her Clear to Create methodology. Together, they dive deep into why so many ambitious women find themselves stuck in cycles of near-success and how to finally break free.

Riana, a renowned expert in emotional and mindset transformation, explores the subconscious patterns that often hold women back from reaching their full potential, both personally and professionally. In this episode, she shares how common emotional blocks and relational dynamics—such as people-pleasing tendencies, fear of rejection, and deeply ingrained limiting beliefs—can keep women from achieving the success they desire.

One of the core concepts Riana discusses is her innovative technique, Quantum Time Release (QTR). Unlike traditional methods that require revisiting painful past experiences, QTR enables individuals to release limiting beliefs and emotions quickly, helping them move forward without the emotional weight that often holds them back. Riana explains how this method provides a powerful way to unlock new possibilities and pave the way for lasting personal growth.

Riana also emphasizes the importance of recognizing and shifting away from the toxic cycles of resistance and resentment that often arise when women feel stuck in their careers or personal lives. She encourages listeners to identify these patterns and take immediate action to break free by aligning their actions with their desires and intentions.

As Riana shares,“When we focus on what we truly want, instead of constantly battling what we fear, we start to magnetize opportunities and people into our lives that are aligned with our goals. The moment we stop resisting is the moment we begin to create with clarity and purpose.”

Listeners will walk away from this episode with practical tools to shift their focus, break through barriers, and take powerful steps toward their desired goals. Riana’s message is clear: it’s not about working harder or pushing through resistance—it’s about stepping into alignment and letting go of what’s no longer serving you.

This episode is a must-listen for anyone who feels stuck in a cycle of frustration, whether in business, personal growth, or relationships, and is ready to take the next step toward creating the life they’ve always wanted.

Listen to the full Ideal Practice episode on Apple Podcasts: https://podcasts.apple.com/us/podcast/147-why-youre-stuck-and-how-to-finally-break-free/id1620799347?i=1000705361641

About Riana Malia

Riana Malia is a Speaker, Author, and Reinvention Strategist—guiding high-achieving women to clear emotional patterns, break subconscious cycles, and lead from deep alignment in life, love, and legacy. She is the creator of the Clear to Create Method and the Quantum Pattern Protocol, proven frameworks that have helped hundreds of women reclaim their voice, rewire their beliefs, and design lives—and love—that are truly extraordinary.

Her work is grounded in neuroscience, quantum healing, and emotional re-patterning, helping women step out of survival mode and into full-spectrum self-expression. Whether through her immersive VIP intensives, her Clear to Create Mastery Experience, or her sold-out Brilliance Brunch connection events, Riana empowers women to become magnetic to what they once thought was impossible—including worthy, soul-aligned love.

Her work has been featured on The Mamahood blog, Brilliant Magazine: Women of Influence, and podcasts like InspiHER’d, Me Time with Maggie Lawson, and From Betrayal To Breakthrough. She was also recognized as one of the “Top 30 Empowering Women Entrepreneurs to Look Out for in 2025” by NY Weekly Magazine.

When she’s not on stage or in session with her private clients, you’ll find her soaking up ocean air, loving life with her husband Pete and daughter Madi, or setting the table for soulful conversations that spark change.

Media Contact
Company Name: Publicity by Christina
Contact Person: Christina Lenkowski
Email: christina@publicityxchristina.com
Phone: 503-989-8073
Country: United States
Website: https://www.publicityxchristina.com

Sorghum United Foundation Welcomes New Team Members and Advisory Board to Strengthen Global Vision and Impact

Sorghum United Foundation is proud to announce the official appointment of several accomplished professionals to its core team, alongside the formation of a distinguished Advisory Board. These additions reflect Sorghum United Foundation’s continued commitment to excellence, innovation, and leadership in championing food security, sustainable agriculture, and community-driven solutions globally.

As the organization expands its reach, Sorghum United Foundation is investing in dynamic talent and visionary leadership to guide its strategic growth. We are thrilled to introduce the following new team members and Advisory Board members, whose combined experience and passion will play an essential role in shaping our next chapter.

New Core Team Members

Rachel Syokau – Grants and Leadership

Rachel Syokau is a seasoned humanitarian program manager with 7+ years’ experience in strategic design, proposal development, and multi-sectoral program implementation. She ensures donor compliance and builds impactful partnerships for community-led change. As Grants and Partnership Lead at Sorghum United Foundation, she spearheads resource mobilization and climate-resilient initiatives. Rachel has managed multi-million-dollar portfolios at Kenya Red Cross and NGOs funded by DFID, USAID/BHA, ECHO, and others. With a background in project management and water engineering, she is passionate about advancing locally led, inclusive solutions in food security, equity, and climate resilience across Africa. Her technical and strategic strengths continue to drive sustainable impact through collaborative, community-based approaches.

Smith Hempstone – Social Media Manager & Content Strategist

Based in Nairobi, Kenya, Smith is a multi-award-winning Creative Director and Filmmaker with nearly a decade of visual storytelling experience. Since launching his career in 2015, he has collaborated with top influencers in Kenya and China, covered 10+ matches at the 2022 FIFA World Cup, and won Best Videographer at the 2024 People’s Choice Awards. His portfolio features brands like Samsung, Infinix, Tecno, Fanta, CeraVe, Carrefour, and more. At Sorghum United Foundation, Smith is the Social Media Manager and Content Strategist, blending creativity with purpose-driven storytelling. He is passionate about crafting impactful narratives that connect communities, elevate voices, and inspire meaningful action across digital platforms.

Derick Odhiambo – Graphic Designer & Visual Branding Specialist

Based in Nairobi, Kenya, Derick is a seasoned Photographer, Creative Director, and Filmmaker with a strong background in fashion and portrait photography. His expertise now spans corporate shoots, documentaries, and global conferences across Africa and Europe. He has worked with top organizations like PrideInn Hotels, Stanford Seed, KAPI, Hope Tech, Imani Orphan Care, and IPPHL. At Sorghum United Foundation, Derick is the Graphic Designer and Visual Branding Specialist, merging storytelling with strategic design to elevate brand identity. Passionate about impactful visuals, he creates work that drives awareness, inspires change, and helps brands grow through compelling, resonant imagery.

Kelvin Kiprop – Video Editor & Motion Graphics Specialist

Based in Nairobi, Kenya, Kelvin is a creative professional with over five years of experience in videography, drone work, motion graphics, and social media content. He creates impactful, story-driven visuals for NGOs, brands, and digital platforms. Known for his disciplined approach and sharp eye for detail, Kelvin is passionate about high-quality storytelling that highlights meaningful impact. He has worked with top travel destinations and international YouTube creators, producing curated content that boosts engagement and enhances message delivery. At Sorghum United Foundation, he serves as the Video Editor & Motion Graphics Specialist, bringing stories to life through dynamic editing, engaging visuals, and a strong commitment to purpose-driven storytelling that connects and inspires audiences.

New Advisory Board Members

Sorghum United Foundation is honored to welcome a newly established Advisory Board composed of respected leaders and change-makers from diverse sectors. Their strategic guidance, global perspective, and collaborative spirit will provide critical support as we work toward a more food-secure, equitable future.

Prof. Gideon Maina – Chairperson of the Advisory Board

Prof. Maina is a distinguished scholar in International Law and Political Science with over 20 years of academic, institutional, and administrative experience across five universities and multiple global institutions. He holds degrees from the University of Cape Town (Ph.D.), Harvard Kennedy School, and the Peace Academy at The Hague. He helped establish Moot Courts in Kenya, co-founded the Kenya Foreign Service Institute, and served as Dean and Acting Vice-Chancellor at Catholic University of Eastern Africa. A consultant in foreign policy, security, and governance, he advises the Kenya Foreign Service Institute, IPSTC, ICRC, and the UN’s International Trade Centre. Passionate about mentorship, ethics, and community service, he is a Globethics and Paul Harris Fellow, committed to advancing Africa’s future.

Mairis Decidido – Advisory Board Member

Based in Brazil, Mairis Decidido is a leading rural producer, entrepreneur, and agri-leader advancing women’s leadership in agriculture. As CEO of Fazenda Bela Vista, she drives sustainable rural production and innovation. She is Founder and President of Agro e Elas, a national network empowering women in agribusiness, and also leads CEIMAP, promoting inclusive agricultural development in Pará. Mairis heads Mulheres do Agro, one of Brazil’s top women’s agriculture movements, championing visibility, education, and economic empowerment for rural women. At Sorghum United Foundation, she serves as an Advisory Board Member, bringing regional expertise, entrepreneurial vision, and a deep commitment to gender-inclusive agricultural development and rural transformation across Brazil.

A.K. Singh – Advisory Board Member

Dr. Anand Kumar Singh is a globally recognized agricultural scientist with over 30 years of leadership in crop science, horticulture, and innovation. As Vice Chancellor of Chandra Shekhar Azad University of Agriculture & Technology, India, he advances climate-smart agriculture and food systems. Formerly Deputy Director General at ICAR, he oversaw 49 national institutions. His career includes leadership at the National Horticulture Board and Coconut Development Board. A prolific author with 160+ papers and 11 books, he’s guided 29 postgraduates and released 750 crop varieties. As the first Indian on the World Vegetable Centre board, he brings global perspective. At Sorghum United Foundation, he serves as Advisory Board Member, championing resilient, nutrition-rich crops and inclusive agricultural transformation.

Harinee Yerra – Advisory Board Member

Harinee Yerra is a passionate Public Health Nutritionist and youth representative on the Advisory Board of Sorghum United Foundation. Based in India, she is pursuing her Master’s in Nutrition and Dietetics with a focus on Public Health Nutrition at Symbiosis International University. Inspired by her personal health journey, Harinee promotes preventive health and indigenous food wisdom. Her work bridges traditional grains like sorghum with modern science to combat food insecurity and metabolic disorders. She has published with Elsevier, won a national innovation contest, and developed millet-based recipes for school feeding programs. At Sorghum United Foundation, she leads youth-centered campaigns that reintroduce nutrient-rich grains to families through games, cartoons, and storytelling—championing a healthier, more resilient future.

Daphne Muchai – Advisory Board Member

Daphne Muchai is the Founder and Executive Director of the Women Farmers Association of Kenya (WoFaAK), a national platform advancing the voice and impact of women in agriculture. With over 30 years of experience in Kenya’s public and private agricultural sectors, she is a seasoned leader in rural development, agribusiness, and gender-responsive value chains. Daphne has worked across East Africa, providing technical and institutional support to drive inclusive agricultural transformation. A certified expert in gender policy and institutional design, she serves on several national advisory bodies championing women’s economic empowerment. At Sorghum United Foundation, Daphne contributes as an Advisory Board Member, guiding inclusive policy, grassroots engagement, and gender equity in climate-resilient agriculture.

A New Chapter in Sorghum United’s Global Mission

The appointment of these new professionals comes at a time of immense opportunity and responsibility. Sorghum United Foundation is not only expanding its presence in the global development space but also deepening its commitment to farmer-led solutions, climate-smart agriculture, and sustainable livelihoods.

CEO, Nate Blum shared:

“We are thrilled to welcome such a powerful and diverse group of leaders into the Sorghum United Foundation family. Each new team member and Advisory Board member brings not only skills but also heart, vision, and a deep commitment to the cause. Their insights will help guide us through our most ambitious goals yet.”

As Sorghum United Foundation continues its work to transform food systems and empower communities through the cultivation, processing, and celebration of sorghum and other indigenous crops, these appointments will ensure the organization is well-positioned to meet both local and global challenges with creativity, resilience, and purpose.

About Sorghum United Foundation

Sorghum United Foundation is a global movement dedicated to improving food security, climate resilience, and sustainable agriculture by revitalizing sorghum and other traditional grains. Through research, advocacy, storytelling, and partnerships, Sorghum United Foundation empowers communities to reclaim indigenous knowledge and transform food systems from the ground up. Our mission is to unite farmers, entrepreneurs, educators, and policymakers in creating a world where everyone has access to nutritious, locally grown food.

Sorghum United Foundation

www.sorghumunited.org

www.sorghosquad.org

Media Contact
Company Name: At Large PR
Contact Person: Jeff Bearden
Email: Send Email
Country: United States
Website: www.atlargepr.com

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Sorghum United Foundation Welcomes New Team Members and Advisory Board to Strengthen Global Vision and Impact

BTL Law Launches Affordable Independent Legal Advice Service for Separation Agreements in Ontario

“Separation Agreement”

BTL Law, a Toronto-based family law firm known for its client-focused approach, is proud to announce the launch of its fixed-fee Independent Legal Advice (ILA) service for individuals entering into separation, prenuptial, or cohabitation agreements in Ontario. This accessible and streamlined legal offering aims to ensure that clients across the province can finalize family law agreements with confidence, fairness, and legal clarity.

For a flat rate of $700 plus HST, BTL Law provides clients with a comprehensive legal service that includes a virtual meeting with a qualified family lawyer, a thorough review of their agreement, guidance on any necessary revisions, and a formal Certificate of Independent Legal Advice. This service is fully remote, allowing individuals to obtain legal counsel from anywhere in Ontario without needing to visit a law office in person.

Meeting a Critical Need in Family Law

In Ontario, while Independent Legal Advice is not legally required to make a separation agreement valid, it is highly recommended. Courts often give more weight to agreements that have been reviewed independently by lawyers, as it demonstrates both parties understood the terms and made informed decisions. BTL Law’s service was created to remove barriers such as high legal fees, limited availability, and geographic distance—making quality legal support more accessible to individuals navigating family changes.

“Too many people hesitate to seek legal advice due to cost or complexity,” said Almas, a spokesperson for BTL Law. “We’ve simplified the process to help families protect their rights and prevent future disputes without unnecessary delays or expenses.”

What Clients Receive

The ILA package from BTL Law includes everything required to meet legal and practical expectations:

A video conference with an experienced Toronto family lawyer.
Detailed review and explanation of the separation, cohabitation, or prenuptial agreement.
Recommendations for changes to improve fairness and reduce risk.
Certificate of Independent Legal Advice provided upon completion.
Remote witnessing and e-signature support to finalize the process efficiently.

This structured and supportive experience allows clients to better understand their legal rights and obligations before signing any long-term family agreement. It also helps to ensure that any signed agreement is more likely to withstand future scrutiny if brought before a judge.

Accessible Legal Services Across Ontario

Recognizing the evolving needs of modern families, BTL Law has built this service to be fully virtual. Clients can complete the entire ILA process online—from initial intake to final signature—making it ideal for individuals in rural areas or those with limited availability to travel.

The firm also acknowledges the financial challenges many clients face during separation or divorce. In addition to offering a competitive flat rate, BTL Law shares information about community resources and legal aid options available to those who qualify. The team is committed to helping all Ontarians access the legal support they need to make sound, enforceable decisions for their future.

Trusted Guidance from a Respected Team

BTL Law is known for its transparent pricing, efficient legal process, and dedication to client care. With years of experience in Ontario family law, the firm has helped hundreds of individuals draft, review, and finalize legally binding agreements that stand the test of time. Their lawyers are not only knowledgeable in the law but also empathetic to the emotional and financial stress that often accompanies family transitions.

About BTL Law

BTL Law is a Toronto-based family law firm offering legal services across Ontario. The firm specializes in family law agreements, divorce proceedings, and mediation support. With a strong focus on client satisfaction, BTL Law aims to make family law services affordable, understandable, and accessible for everyone.

Media Contact
Company Name: BTL Law P.C.
Contact Person: Media Relations
Email: Send Email
Phone: (647) 254-0909
Address:45 Sheppard Ave E Suite 500D
City: Toronto
State: Ontario
Country: Canada
Website: https://separationagreementontario.ca/

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: BTL Law Launches Affordable Independent Legal Advice Service for Separation Agreements in Ontario

Vision Office Interiors Encourages Summer Office Renovations with Affordable, Stylish Furniture Solutions

As the summer season approaches, Vision Office Interiors is encouraging businesses across Central Florida to take advantage of the warmer months to refresh and revitalize their office spaces.

Known for its high-quality new and pre-owned office furniture, the Longwood-based company Vision Office Interiors is helping businesses of all sizes upgrade their work environments with affordable, ergonomic, and modern solutions just in time for summer renovations.

From startups planning their first layout to established firms looking to modernize outdated setups, summer is an ideal time to complete office upgrades with minimal disruption to operations. Vision Office Interiors offers a wide selection of stylish workstations, cubicles, ergonomic seating, collaborative furniture, and storage options to transform any office into a more productive, attractive, and comfortable environment.

“Summer is the perfect time for businesses to rethink their office space and create an environment that works better for their team,” said Dinah King at Vision Office Interiors. “Whether it’s improving workflow with new layouts or investing in ergonomic furniture to boost employee well-being, we’re here to guide each client through the process and provide solutions that fit their budget.”

With access to premium brands like Herman Miller, Steelcase, Teknion, and Allsteel—often available in gently used, refurbished condition—Vision Office Interiors provides both value and versatility. Their experienced team also offers professional space planning, delivery, and installation services to ensure each renovation is completed smoothly and efficiently.

In a season of renewal and growth, Vision Office Interiors is making it easy for companies to refresh their workspaces and align their physical environment with evolving goals and team needs.

Get your office summer-ready! Visit www.visionofficeinteriors.com to schedule a consultation and start planning your renovation today.

About Vision Office Interiors

Vision Office Interiors is a leading provider of high-quality new and used office furniture in Central Florida. Specializing in affordable, stylish, and ergonomic solutions, they help businesses create functional workspaces that enhance productivity and comfort. With a wide range of furniture options and exceptional customer service, Vision Office Interiors is committed to meeting the unique needs of every office environment.

Media Contact
Company Name: Vision Office Interiors
Contact Person: Dinah King
Email: Send Email
Phone: 321-203-2759
Address:830 South Ronald Reagan Blvd #182
City: Longwood
State: Florida
Country: United States
Website: https://visionofficeinteriors.com/

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Vision Office Interiors Encourages Summer Office Renovations with Affordable, Stylish Furniture Solutions

Iris Tuesday’s Isabel’s Garden Garners Critical Acclaim and Grand Jury Award Nomination at Cordillera Film Festival

The lights go down. Everyone goes quiet. The screen lights up. We dive into a tale full of love, sadness, and strength. Isabel’s Garden is more than just a movie. It’s a heartfelt trip through sorrow and healing. Now, it’s getting a big award nomination. The Cordillera International Film Festival has nominated Isabel’s Garden for its top prize: the Grand Jury Award for Best of Fest. It’s a huge moment for director Kit Rich and producer Manuel “Manny” Lozano. It shows their hard work pays off.

A Festival for the Best

The Cordillera International Film Festival isn’t your regular contest. It’s a big deal in indie films. Only the greatest movies get nominations here. Lots of famous film people attend. They show amazing films that push the envelope. Isabel’s Garden joins these ranks with its strong story and emotions.

Winning the Grand Jury Award means honoring films that change independent cinema. Past winners have gotten big deals, and even Oscar nods. This nomination tells us Isabel’s Garden is something unique. It speaks to anyone who has lost someone, loved deeply, and tried to heal.

A Real-Life Story

Kit Rich didn’t dream up Isabel’s Garden easily. She pulled from her own life. Personal experiences with stepfamilies, loss, and healing inspired the film. It follows Maya, played by Karen David, a stepmom facing sadness while connecting with Isabel, her late husband’s daughter. Gabriela Flores shines as Isabel, a girl full of sorrow. Their journey is raw and real. Though messy, it grows into something beautiful—connection, healing, and hope.

The garden in the movie isn’t just pretty plants. It holds memories, giving peace and a fresh start. As Maya and Isabel move to the garden, they find healing. It means love blooms, even in sadness. This idea touched many hearts. When the movie ended, the theater was quiet—until sniffles turned into applause.

Defying the Odds to Shine

Creating Isabel’s Garden was tough. The crew worked on a tight budget, filming 172 scenes with only one camera while dealing with COVID-19 rules. Every day brought challenges—rushed schedules, tough locations, and many bumps in the road.

At times, it felt like they couldn’t make it. But quitting wasn’t an option. Rich and Lozano believed in their story. They knew it could touch hearts. Their hard work made winning at Cordillera even sweeter. Isabel’s Garden stood out among many entries, showing that heart and vision matter more than money.

What This Nomination Means

The Cordillera International Film Festival only picks films that leave a mark. Isabel’s Garden nails this. It tells a tale of love, loss, and blending families. The acting hits hard. The cinematography pulls at your heart. The script brings emotions to life.

One critic Zhi Ho says, “The mix of loss, healing, and new bonds creates a picture that speaks to anyone facing tough times. It shows how small acts of care can help us heal.” People walked out with tears and smiles. Weeks later, the characters stayed with them, touching their hearts. Cordillera honors films like these, which stick with you even after the end credits.

What’s Next for Isabel’s Garden?

This nomination isn’t the final chapter. It’s only the beginning. With Isabel’s Garden up for the Grand Jury Award, it’s destined for more stars. More people are noticing Rich and Lozano than ever. They are ready for new projects—a rom-com and a fun Christmas movie. Fans can’t wait for what’s next.

Rich once called Isabel’s Garden a labor of love. Every challenge, sleepless night, and moment of fear has led to this. Now, with a nomination placing it among the year’s best indie films, that love is coming back tenfold.

As the festival nears, one thing is clear—Isabel’s Garden keeps growing.

Media Contact
Company Name: Iris Tuesday
Contact Person: Manuel Rafael
Email: Send Email
City: Los Angeles
State: CA
Country: United States
Website: www.iristuesday.com

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Iris Tuesday’s Isabel’s Garden Garners Critical Acclaim and Grand Jury Award Nomination at Cordillera Film Festival

Ycoficial YouCine APK Launches as the Ultimate Full HD Streaming Destination

With YouCine download, streaming movies, series, anime, and live sports in Full HD is easier than ever. With both local and international content available, this app is quickly becoming you and millions of others entertainment’s favourite go to platform.

This app is any streamer’s one stop shop, conveniently designed to meet your variety and quality multiversal needs. Be it local TV shows or even Hollywood blockbusters, YouCine APK brings everything to your screen in crisp 1080p.

What is the YouCine APK?

YouCine download is an Android App offering an extensive library of multimedia content. Movies and series? Check. Anime? Of course! Even live football matches, its got you covered for every catering genre and age group.

YouCine APK Unlike many traditional streaming platforms which have subscription fees and geo restrictions, YouCine APK takes a much easier approach to content availability. Users can enjoy uninterrupted content without the hassle of too many ads or complex sign up processes.

Highlights That YouCine APK Offers

The streaming quality is one of the main highlights of YouCine APK YouCine download. Most content is available in Full HD and 1080p resolution which ensures high-definition experience scaling up to bigger screens.

Besides quality, the categorization is equally commendable. If you feel like watching a drama series or a family movie, or if you are into action anime, YouCine caters to all your requires with easy accessibility.

The live TV and football streaming function stands as a huge advantage as well. Sports buffs can watch their favorite matches live and do away with overpriced cable subscriptions and streaming services.

Why YouCine APK Is Preferred Over Other Streaming Apps?

Today, there is no shortage of streaming apps, but YouCine APK YouCine download makes its mark for its effortless design, quality, and variety. YouCine differs from other apps that restrict access based on location; it offers a global library of shows and movies.

Not only is the app lightweight and easily installable, but it also does not take up sizable storage on one’s device. It works seamlessly on older Android phones and even supports external media players.

YouCine stands out mainly for its child-friendly section. Parents can rest assured that there is an area packed with cartoons and educational materials specially tailored for kids.

Steps To Follow For YouCine APK Download And Installation

In the case of YouCine, the first step is to download the YouCine APK file and install it on your Android device. You will not find it in Google’s Play Store, meaning it is necessary to get it from elsewhere, preferably reliable.

After downloading, Microsoft Edge should be configured to permit installations from unknown sources. Getting it ready like that will require only a couple of minutes. After launching the application, users will be able to start streaming immediately without the need of an account or subscription.

Check the official website or verified APK sources to stay updated with the new functionalities and enhancements added into the app.

Is YouCine APK Safe and Legal?

Safety and legality are a primary concern when talking about any application that provides free streaming content. The YouCine APK download has been largely praised for its protective measures, with few advertisements and not a single piece of malicious software noted in well known versions.

Nevertheless, because it gives users a wide variety of content some of which may be pirated or unlicensed, people should be careful regarding the law in their area. A VPN can aid improve privacy when using the app.

It is generally advisable to obtain the app from reputable sites as these will not contain fake or altered versions that could be a threat to your device.

Conclusion

YouCine APK YouCine download is an amazing entertainment repository for those that relish accessing videos without restrictions of subscriptions, regional limitations, or even bounds of time. The increasing popularity of the app can be attributed to its simple interface, ease of use, diverse content catalogue, and ability to stream in HD.

For those fond of movies, TV series, anime, child shows, and even live football matches, YouCine APK has it all. Just ensure to download it securely and enjoy the endless fun that ensues.

Especially in the modern era, all forms of entertainment can be found with a quick tap; which is why having YouCine is a good option to guarantee that there’s never a dull moment.

Media Contact
Company Name: Ycoficial
Contact Person: Cristina
Email: Send Email
City: Brasília
Country: Brazil
Website: https://ycoficial.net/

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Ycoficial YouCine APK Launches as the Ultimate Full HD Streaming Destination

Award-Winning Memoir “Washing the Inside of the Cup” Inspires Readers to Embrace a Life Transformed by Faith

In a powerful testament to faith, resilience, and divine transformation, Washing the Inside of the Cup: My journey of walking in the Spirit by Cheryl Lynn has emerged as a beacon of hope for readers seeking spiritual renewal. This deeply personal, award-winning memoir has garnered widespread acclaim, receiving a Bronze Award in two categories, Personal Triumph and Spirituality, from the Nonfiction Authors Association and the Literary Titan Silver Book Award.

In Washing the Inside of the Cup, Cheryl Lynn candidly recounts her 20-year journey through physical, emotional, mental, and spiritual abuse, revealing how total surrender to God brought her unshakable peace, clarity, and supernatural transformation. Drawing on scripture, divine encounters, and the spiritual insight she received along the way, Cheryl delivers a message of healing and hope that resonates far beyond the pages of her book.

Her compelling narrative invites readers into her walk with God—a path that began in despair but was divinely redirected through grace and revelation. From surviving trauma to experiencing a vision of Jesus, Cheryl’s story illustrates the power of a life wholly devoted to the Lord.

“This is not just a memoir,” said Literary Titan. “It’s a conversation—honest, vulnerable, and deeply spiritual. Cheryl Lynn is not preaching; she’s sharing, guiding, and loving the reader through her words.”

With emotional honesty and unwavering faith, Washing the Inside of the Cup calls readers to “wash the inside of their cup”—to seek the Lord with all their heart and to live fully surrendered. The result, as Cheryl attests, is not just survival but transformation through the gifts of the Spirit.

Don’t wait to experience the life-changing power of Washing the Inside of the Cup. Whether you’re seeking healing from past wounds, longing for a deeper connection with God, or simply craving peace in the midst of life’s storms, this book will speak directly to your heart. Order your copy today on Amazon or Barnes & Noble and begin your own journey of spiritual renewal and divine intimacy.

About the Author

Cheryl Lynn is a multiple award-winning author, survivor, devoted Christian, mother, grandmother, and retired nurse. She is the author of Washing the Inside of the Cup: My journey of walking in the Spirit (Christian Faith Publishing), a memoir of spiritual transformation born from personal trials and triumphs.

Raised in a Christian home and born again at 15, Cheryl entered a 20-year-long abusive marriage at age 23. Through this harrowing period, she leaned wholly on her faith, ultimately experiencing a divine renewal that reshaped her life and walk with God. A passionate believer in God’s grace, Cheryl now dedicates her life to sharing the truth of healing through spiritual surrender.

Cheryl homeschooled her seven children for ten years while pursuing higher education, earning degrees in nursing and business. Over a 20-year nursing career, she served in leadership roles and contributed to public health in both government and corporate sectors. She also operated her own health food business.

Now residing in Texas with her second husband, Cheryl treasures time with her children and 14 grandchildren. When she’s not writing or speaking, she enjoys gardening, soaking in her swim spa, and immersing herself in the Word of God. Her life is a living testimony to the redeeming power of faith and the mercy of a God who restores.

To learn more about Cheryl Lynn’s story, explore exclusive content, or inquire about speaking engagements, visit her official website at CherylLynnBook.com.

Follow her Facebook page at facebook.com/washingtheinsideofthecup for uplifting posts, book updates, scripture reflections, and encouragement straight from Cheryl’s heart.

Media Contact
Company Name: Literary Titan
Contact Person: Cheryl Lynn
Email: Send Email
Country: United States
Website: https://www.cheryllynnbook.com/